Comparative Pharmacology
Head-to-head clinical analysis: ALPHAZINE versus CHLORPROMAZINE HYDROCHLORIDE INTENSOL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ALPHAZINE versus CHLORPROMAZINE HYDROCHLORIDE INTENSOL.
ALPHAZINE vs CHLORPROMAZINE HYDROCHLORIDE INTENSOL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Alpha-2 adrenergic receptor agonist in the central nervous system, reducing sympathetic outflow from the brainstem, leading to decreased peripheral vascular resistance and heart rate.
Chlorpromazine is a phenothiazine antipsychotic that blocks postsynaptic dopamine D2 receptors in the central nervous system, particularly in the mesolimbic and mesocortical pathways. It also exhibits antagonism at serotonin 5-HT2, histamine H1, alpha-1 adrenergic, and muscarinic receptors, contributing to its sedative, antiemetic, and hypotensive effects.
Adults: IM/SC 10 mg every 4 hours as needed, maximum 40 mg/day; IV 5 mg over 1 minute, may repeat in 20-30 minutes, maximum 10 mg.
Oral: 25-50 mg 2-3 times daily, up to 1000 mg/day in severe psychosis. IM: 25-50 mg every 1-4 hours until controlled, then switch to oral.
None Documented
None Documented
5-7 hours; prolonged to 10-15 hours in renal impairment.
15-30 hours; prolonged in elderly and hepatic impairment; active metabolites (e.g., 7-hydroxychlorpromazine) have longer half-lives (up to 12-24 hours)
Primarily renal (60-70% unchanged), 20-30% biliary/fecal as metabolites.
Renal (70-80% as metabolites, <1% unchanged); biliary/fecal (~20-30%)
Category C
Category C
Antipsychotic
Antipsychotic